{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:34:00Z","timestamp":1790213640166,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["2022-LCYJ-PY-40"],"award-info":[{"award-number":["2022-LCYJ-PY-40"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["QRX17142"],"award-info":[{"award-number":["QRX17142"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["YKK21066"],"award-info":[{"award-number":["YKK21066"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.intimp.2024.112743","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T02:32:22Z","timestamp":1722479542000},"page":"112743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity"],"prefix":"10.1016","volume":"140","author":[{"given":"Kunzhan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-6298","authenticated-orcid":false,"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112743_b0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.intimp.2024.112743_b0010","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"10.1016\/j.intimp.2024.112743_b0015","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.112743_b0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","article-title":"T cells as therapeutic targets in SLE","volume":"6","author":"Crisp\u00edn","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"24","key":"10.1016\/j.intimp.2024.112743_b0025","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112743_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102861","article-title":"Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target","volume":"132","author":"Lou","year":"2022","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12660","article-title":"Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: a B-cell immunomics approach","volume":"284","author":"Tipton","year":"2018","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2024.112743_b0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/ijms19030784","article-title":"The inside story of adenosine","volume":"19","author":"Camici","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112743_b0045","doi-asserted-by":"crossref","first-page":"7019398","DOI":"10.1155\/2018\/7019398","article-title":"The role of extracellular adenosine generation in the development of autoimmune diseases","volume":"2018","author":"Morandi","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2024.112743_b0050","first-page":"85","article-title":"Regulation of inflammation by adenosine","volume":"4","author":"Hask\u00f3","year":"2013","journal-title":"Front. Immunol. (1664-3224 (Print))"},{"issue":"13","key":"10.1016\/j.intimp.2024.112743_b0055","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hask\u00f3","year":"2000","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.intimp.2024.112743_b0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/biom12030418","article-title":"Adenosine-metabolizing enzymes, adenosine kinase and adenosine deaminase, in cancer","volume":"12","author":"Zhulai","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102709","article-title":"The roles of adenosine deaminase in autoimmune diseases","volume":"20","author":"Gao","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112743_b0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-018-8984-9","article-title":"Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity","volume":"66","author":"Gao","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112743_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2023.04.010","article-title":"Correlation of serum adenosine deaminase activity with disease activity in patients with primary Sj\u00f6gren's syndrome","volume":"258","author":"Zhang","year":"2023","journal-title":"Immunol. Lett."},{"issue":"21","key":"10.1016\/j.intimp.2024.112743_b0080","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.3748\/wjg.v23.i21.3876","article-title":"Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis","volume":"23","author":"Torgutalp","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12865-022-00477-5","article-title":"Increased serum adenosine deaminase activity in patients with adult-onset Still's disease","volume":"23","author":"Xu","year":"2022","journal-title":"BMC Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112743_b0090","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00296-011-1836-8","article-title":"Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern","volume":"32","author":"Saghiri","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"6","key":"10.1016\/j.intimp.2024.112743_b0095","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112743_b0100","first-page":"9","article-title":"Adenosine production by human B cells and B cell-mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood (1528-0020 (Electronic))"},{"issue":"4","key":"10.1016\/j.intimp.2024.112743_b0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/eji.201343866","article-title":"Extracellular adenosine controls NKT-cell-dependent hepatitis induction","volume":"44","author":"Subramanian","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-019-0724-7","article-title":"CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K\/AKT signaling by inducing Rap1-mediated membrane localization of P110\u03b2 and predicts poor prognosis","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"40","key":"10.1016\/j.intimp.2024.112743_b0115","first-page":"e4989","article-title":"Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection","volume":"95","author":"Cai","year":"2016","journal-title":"Medicine (Abingdon)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/gastro\/goaa048","article-title":"Skewed CD39\/CD73\/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B","volume":"9","author":"Zhou","year":"2021","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"issue":"5","key":"10.1016\/j.intimp.2024.112743_b0125","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1189\/jlb.5A0816-346R","article-title":"Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression","volume":"101","author":"Kim","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112743_b0130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus","volume":"66","author":"Yokogawa","year":"2014","journal-title":"Arthritis & Rheumatology (Hoboken, N.J.)"},{"issue":"7","key":"10.1016\/j.intimp.2024.112743_b0135","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/art.42840","article-title":"Phosphatidic acid promoting the generation of interleukin-17A producing double-negative T cells by enhancing mTORC1 signaling in lupus","volume":"76","author":"Li","year":"2024","journal-title":"Arthritis & Rheumatology (Hoboken, N.J.)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112743_b0140","doi-asserted-by":"crossref","first-page":"e1082703","DOI":"10.1080\/2162402X.2015.1082703","article-title":"Phenotypic and functional characteristics of CD39(high) human regulatory B cells (Breg)","volume":"5","author":"Figueir\u00f3","year":"2016","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.intimp.2024.112743_b0145","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.4049\/jimmunol.1400336","article-title":"A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production","volume":"193","author":"Kaku","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112743_b0150","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jcp.29932","article-title":"The role of the CD39-CD73-adenosine pathway in liver disease","volume":"236","author":"Wang","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0155","doi-asserted-by":"crossref","first-page":"e000610","DOI":"10.1136\/jitc-2020-000610","article-title":"Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade","volume":"8","author":"Yang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2024.112743_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102491","article-title":"Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39(-)CD73 signaling pathway","volume":"113","author":"Dang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112743_b0165","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3389\/fimmu.2018.02581","article-title":"ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity","volume":"9","author":"Silva-Vilches","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112743_b0170","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1096\/fj.08-107458","article-title":"Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function","volume":"22","author":"Cs\u00f3ka","year":"2008","journal-title":"FASEB J.: Off. publication of the Federation of American Societies for (1530-6860 (Electronic))"},{"issue":"1","key":"10.1016\/j.intimp.2024.112743_b0175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","article-title":"A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells","volume":"111","author":"Zarek","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.intimp.2024.112743_b0180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/jir.2018.0169","article-title":"Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients","volume":"39","author":"Tang","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.intimp.2024.112743_b0185","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","article-title":"An etiopathogenic role for the type I IFN system in SLE","volume":"22","author":"R\u00f6nnblom","year":"2001","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112743_b0190","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/ndt\/gfq860","article-title":"The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis","volume":"26","author":"Adhya","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112743_b0195","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112743_b0200","first-page":"2211","article-title":"Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator\/B cell-activating factor\/TNF ligand superfamily-13B","volume":"181","author":"Harigai","year":"2008","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"4","key":"10.1016\/j.intimp.2024.112743_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/nep.12047","article-title":"The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside","volume":"18","author":"Yap","year":"2013","journal-title":"Nephrology (Carlton, Vic.)"},{"issue":"5\u20136","key":"10.1016\/j.intimp.2024.112743_b0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00011-022-01554-6","article-title":"Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus","volume":"71","author":"Bolouri","year":"2022","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112743_b0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-020-00978-5","article-title":"T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update","volume":"23","author":"Chen","year":"2021","journal-title":"Curr. Rheumatol. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924012645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:56:24Z","timestamp":1786362984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924012645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S1567576924012645"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112743","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The reduced frequency of CD39+CD73+ B cell subsets in SLE patients is correlated with disease activity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112743"}}